CTKYY yields 7380.07% · JNJ yields 2.13%● Live data
📍 CTKYY pulled ahead of the other in Year 1
Combined, CTKYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTKYY + JNJ for your $10,000?
CooTek (Cayman) Inc. operates as a mobile internet company in the United States, the People's Republic of China, and internationally. The company offers Fengdu Novel, a mobile application that provides users with free online novels; and Fengdu Literature, a platform covering 14 major categories of male and female preferred content, including genres of romance, fantasy, science fiction, history, and others. It also provides casual games, such as dress-up games, including Catwalk Beauty, Truth Runner, and Love Fantasy; simulation games comprising Farm Hero and Idle Land King Tycoon; puzzle games, such as Hi Hamster; and educational games consisting of Puzzle No. 1 and Idiom Hero. In addition, the company offers TouchPal Smart Input, an input method for mobile devices that supports approximately 110 languages and available on both Android and iOS operating systems. It distributes its products and acquires users primarily through user downloads from digital distribution platforms and social media. The company was founded in 2008 and is headquartered in Shanghai, the People's Republic of China.
Full CTKYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.